Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 4
1993 9
1994 6
1995 9
1996 6
1997 10
1998 11
1999 16
2000 27
2001 14
2002 4
2003 13
2004 14
2005 18
2006 18
2007 23
2008 16
2009 19
2010 16
2011 14
2012 19
2013 16
2014 21
2015 21
2016 28
2017 20
2018 33
2019 21
2020 24
2021 18
2022 24
2023 31
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

505 results

Results by year

Filters applied: . Clear all
Page 1
An update on the CNS manifestations of neurofibromatosis type 2.
Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S. Coy S, et al. Acta Neuropathol. 2020 Apr;139(4):643-665. doi: 10.1007/s00401-019-02029-5. Epub 2019 Jun 4. Acta Neuropathol. 2020. PMID: 31161239 Free PMC article. Review.
Neurofibromatosis Type 2.
Ardern-Holmes S, Fisher G, North K. Ardern-Holmes S, et al. J Child Neurol. 2017 Jan;32(1):9-22. doi: 10.1177/0883073816666736. Epub 2016 Sep 29. J Child Neurol. 2017. PMID: 27655473 Review.
Neurofibromatosis type 2: Hearing preservation and rehabilitation.
Jia H, El Sayed MME, Smail M, Mosnier I, Wu H, Sterkers O, Kalamarides M, Bernardeschi D. Jia H, et al. Neurochirurgie. 2018 Nov;64(5):348-354. doi: 10.1016/j.neuchi.2018.09.003. Epub 2018 Oct 9. Neurochirurgie. 2018. PMID: 30314805 Review.
Hearing Rehabilitation in Neurofibromatosis Type 2.
North HJD, Lloyd SKW. North HJD, et al. Adv Otorhinolaryngol. 2018;81:93-104. doi: 10.1159/000485526. Epub 2018 Apr 6. Adv Otorhinolaryngol. 2018. PMID: 29794459 Review.
Hearing optimisation in neurofibromatosis type 2: A systematic review.
Lloyd SKW, King AT, Rutherford SA, Hammerbeck-Ward CL, Freeman SRM, Mawman DJ, O'Driscoll M, Evans DG. Lloyd SKW, et al. Clin Otolaryngol. 2017 Dec;42(6):1329-1337. doi: 10.1111/coa.12882. Epub 2017 Apr 26. Clin Otolaryngol. 2017. PMID: 28371358 Review.
Neurofibromatosis 1 and 2.
Pollack IF, Mulvihill JJ. Pollack IF, et al. Brain Pathol. 1997 Apr;7(2):823-36. doi: 10.1111/j.1750-3639.1997.tb01067.x. Brain Pathol. 1997. PMID: 9161732 Free PMC article. Review.
Natural history of neurofibromatosis Type 2 tumors.
Heros RC. Heros RC. J Neurosurg. 2012 Jul;117(1):107-8; discussion 108. doi: 10.3171/2012.1.JNS112304. Epub 2012 Apr 13. J Neurosurg. 2012. PMID: 22503124 No abstract available.
Neurofibromatosis type 2.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Sathornsumetee S, et al. Neurology. 2007 Mar 27;68(13):E14. doi: 10.1212/01.wnl.0000257828.56178.9f. Neurology. 2007. PMID: 17389295 No abstract available.
505 results